The Goldman Sachs Group Downgrades Hamilton Lane (NASDAQ:HLNE) to Sell

The Goldman Sachs Group downgraded shares of Hamilton Lane (NASDAQ:HLNE) from a neutral rating to a sell rating in a report released on Monday, Marketbeat.com reports. The Goldman Sachs Group currently has $139.00 price objective on the stock.

A number of other brokerages have also recently issued reports on HLNE. Morgan Stanley upped their target price on Hamilton Lane from $182.00 to $190.00 and gave the stock an “equal weight” rating in a report on Monday, November 11th. UBS Group raised their price objective on shares of Hamilton Lane from $150.00 to $185.00 and gave the company a “neutral” rating in a report on Tuesday, October 22nd. Keefe, Bruyette & Woods reduced their target price on shares of Hamilton Lane from $215.00 to $167.00 and set a “market perform” rating on the stock in a report on Friday, December 20th. JPMorgan Chase & Co. raised their price target on shares of Hamilton Lane from $134.00 to $175.00 and gave the company a “neutral” rating in a research note on Thursday, November 7th. Finally, Wells Fargo & Company boosted their price objective on shares of Hamilton Lane from $189.00 to $194.00 and gave the stock an “equal weight” rating in a research note on Thursday, December 12th. One investment analyst has rated the stock with a sell rating and six have issued a hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $175.00.

Hamilton Lane Stock Down 2.3 %

HLNE stock opened at $146.74 on Monday. The firm has a 50-day moving average price of $176.60 and a 200-day moving average price of $159.16. Hamilton Lane has a 12 month low of $103.42 and a 12 month high of $203.72. The company has a current ratio of 3.37, a quick ratio of 3.37 and a debt-to-equity ratio of 0.24. The stock has a market capitalization of $8.13 billion, a P/E ratio of 31.83 and a beta of 1.24.

Hamilton Lane (NASDAQ:HLNE) last issued its quarterly earnings data on Wednesday, November 6th. The company reported $1.07 EPS for the quarter, beating the consensus estimate of $1.06 by $0.01. The business had revenue of $150.00 million during the quarter, compared to the consensus estimate of $151.55 million. Hamilton Lane had a net margin of 28.03% and a return on equity of 35.59%. The firm’s revenue was up 18.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.89 EPS. As a group, equities research analysts anticipate that Hamilton Lane will post 4.87 EPS for the current fiscal year.

Hamilton Lane Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, January 7th. Investors of record on Monday, December 16th will be issued a $0.49 dividend. The ex-dividend date of this dividend is Monday, December 16th. This represents a $1.96 annualized dividend and a yield of 1.34%. Hamilton Lane’s payout ratio is 42.52%.

Institutional Trading of Hamilton Lane

Large investors have recently bought and sold shares of the business. FMR LLC boosted its position in shares of Hamilton Lane by 239.9% during the 3rd quarter. FMR LLC now owns 5,557 shares of the company’s stock valued at $936,000 after purchasing an additional 3,922 shares in the last quarter. Oppenheimer Asset Management Inc. boosted its holdings in shares of Hamilton Lane by 13.3% during the 2nd quarter. Oppenheimer Asset Management Inc. now owns 45,956 shares of the company’s stock worth $5,679,000 after buying an additional 5,412 shares in the last quarter. Retirement Systems of Alabama acquired a new stake in shares of Hamilton Lane during the 3rd quarter worth approximately $8,291,000. Icon Wealth Advisors LLC bought a new stake in shares of Hamilton Lane in the 3rd quarter valued at $819,000. Finally, Royce & Associates LP acquired a new position in shares of Hamilton Lane during the 3rd quarter valued at $538,000. 97.40% of the stock is currently owned by institutional investors and hedge funds.

About Hamilton Lane

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.